Caught Our Notice: Using this research tool? You’d better ask first

Via Wikimedia

Title: Patient Education After CABG: Are We Teaching the Wrong Information?

What Caught Our Attention: We’ve written about the controversy surrounding a commonly used tool to measure whether patients are sticking to their drug regimen, known as the Morisky Medication Adherence Scale (MMAS-8). It can cost thousands of dollars — and using it without payment/permission earns researchers a call from a collector, who has used legal threats to compel multiple teams to withdraw their papers (a phenomenon we wrote about in Science). The creator of the tool argues it’s copyrighted, and demanding fees ensures researchers use it properly, which avoids putting patients at risk. We’ve found a notice (paywalled, tsk-tsk) that reveals another group of authors used the tool without permission and, according to the notice, “incorrectly.”

Journal: Circulation

Authors: Corey Bradley, Madelyn Burkart, and Ravi Agarwala

Affiliations: Wake Forest University, NC, USA

The Notice:

For the American Heart Association’s 2016 Scientific Sessions abstract #13254 by Corey Bradley, Madelyn Burkart, and Ravi Agarwala (“Patient Education After CABG: Are We Teaching the Wrong Information?” Circulation. 2016;134(suppl 1):A13254), the authors would like to retract this abstract due to errors in the analysis. There was a licensing issue with the MMAS-8 but, more importantly, the analysis of MMAS-8 data was incorrectly performed. These errors were not intentional. The authors sincerely regret these errors and apologize for any inconvenience they cause.

Date of Article: November 2016

Times Cited, according to Clarivate Analytics’ Web of Science:  Zero

Date of Notice:  12/18/2017

Like Retraction Watch? Consider making a tax-deductible contribution to support our growth. You can also follow us on Twitter, like us on Facebook, add us to your RSS reader, sign up on our homepage for an email every time there’s a new post, or subscribe to our daily digest. Click here to review our Comments Policy. For a sneak peek at what we’re working on, click here. If you have comments or feedback, you can reach us at retractionwatchteam@gmail.com.

One thought on “Caught Our Notice: Using this research tool? You’d better ask first”

Leave a Reply

Your email address will not be published. Required fields are marked *